These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 2450411)
1. Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporin-treated renal allograft recipients. Cohen H; Neild GH; Patel R; Mackie IJ; Machin SJ Thromb Res; 1988 Jan; 49(1):91-101. PubMed ID: 2450411 [TBL] [Abstract][Full Text] [Related]
2. In vivo platelet activation with in vitro hyperaggregability to arachidonic acid in renal allograft recipients. Frampton G; Parbtani A; Marchesi D; Duffus P; Livio M; Remuzzi G; Cameron JS Kidney Int; 1983 Mar; 23(3):506-13. PubMed ID: 6405075 [TBL] [Abstract][Full Text] [Related]
3. Platelet function studies during and after infusions of ZK 36374, a stable prostacyclin analogue, to healthy volunteers. Yardumian DA; Mackie IJ; Brennan EC; Bull H; Machin SJ Haemostasis; 1986; 16(1):20-6. PubMed ID: 2422095 [TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost). Pedvis LG; Wong T; Frojmovic MM Thromb Haemost; 1988 Apr; 59(2):323-8. PubMed ID: 2455359 [TBL] [Abstract][Full Text] [Related]
5. Oral naftidrofuryl prevents platelet hyperreactivity ex vivo and inhibits functional desensitization to prostacyclin in hypercholesterolemic rabbits. Weber AA; Hohlfeld T; Strobach H; Schrör K J Cardiovasc Pharmacol; 1993 Feb; 21(2):332-8. PubMed ID: 7679170 [TBL] [Abstract][Full Text] [Related]
6. Platelet sensitivity in vitro to the prostacyclin analogue iloprost in diabetic patients. Vicari AM; Macagni A; Pozza G Horm Metab Res; 1989 Nov; 21(11):616-8. PubMed ID: 2480323 [TBL] [Abstract][Full Text] [Related]
7. Effect of Iloprost (ZK 36 374), a novel prostacyclin analogue, on ADP-induced platelet aggregation. Wadenvik H; Kutti J Acta Haematol; 1985; 73(4):224-7. PubMed ID: 2414956 [TBL] [Abstract][Full Text] [Related]
9. Changes in some aspects of platelet function with improvement of glycaemic control over 6 months. Collier A; Tymkewycz PM; Matthews DM; Jones RL; Clarke BF Diabetes Res; 1987 Jun; 5(2):79-82. PubMed ID: 2443296 [TBL] [Abstract][Full Text] [Related]
10. The novel effect of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood. Saniabadi AR; Lowe GD; Belch JJ; Forbes CD; Prentice CR; Barbenel JC Thromb Haemost; 1983 Oct; 50(3):718-21. PubMed ID: 6196854 [TBL] [Abstract][Full Text] [Related]
11. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood. Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771 [TBL] [Abstract][Full Text] [Related]
13. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia. Schrör K; Löbel P; Steinhagen-Thiessen E Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819 [TBL] [Abstract][Full Text] [Related]
14. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro. Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909 [TBL] [Abstract][Full Text] [Related]
15. Preservation of platelet function in cryopreserved platelet concentrates with prostacyclin. Johnson EJ; Mackie IJ; Machin SJ; Brozović B Clin Lab Haematol; 1984; 6(2):141-4. PubMed ID: 6207975 [TBL] [Abstract][Full Text] [Related]
16. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting. Michel G; Seipp U Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087 [TBL] [Abstract][Full Text] [Related]
17. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man. O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004 [TBL] [Abstract][Full Text] [Related]
18. Interactions between prostacyclin analogue ZK 36374 and heparin in their effects upon platelet function. Yardumian DA; O'Flynn K; Linch DC; Machin SJ Br J Haematol; 1987 Mar; 65(3):325-30. PubMed ID: 2436647 [TBL] [Abstract][Full Text] [Related]
19. In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin. Russo I; Traversa M; Bonomo K; De Salve A; Mattiello L; Del Mese P; Doronzo G; Cavalot F; Trovati M; Anfossi G Obesity (Silver Spring); 2010 Apr; 18(4):788-97. PubMed ID: 19834474 [TBL] [Abstract][Full Text] [Related]
20. Effects of iloprost (ZK 36374), a prostacyclin derivative, on platelet function after ischaemic exercise in patients with stable angina pectoris. Grauso F; Biagi G; Puddu P; Bugiardini R; Capelli M; Coccheri S Thromb Res; 1987 Oct; 48(2):131-43. PubMed ID: 2447664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]